Showing results (511-520 of 2,410) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|January 31, 2024
Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antiviralsJennie H Best, Sheila R Reddy, Eunice Chang, et al.Journal of Medical Economics|January 25, 2024
Real world treatment patterns, healthcare resource use and costs in patients with advanced or metastatic non-small cell lung cancer by EGFR mutation typePratyusha Vadagam, Dexter Waters, Inyoung Lee, et al.Journal of Medical Economics|April 5, 2024
Cost-effectiveness and impact on infections and associated antimicrobial resistance of 20-valent pneumococcal conjugate vaccine in US children previously immunized with PCV13Mark H Rozenbaum, Liping Huang, Alejandro Cane, et al.Journal of Medical Economics|March 15, 2024
Cost-efficiency and budget-neutral expanded access modeling of the novel PD-1 inhibitor toripalimab versus pembrolizumab in recurrent or metastatic nasopharyngeal carcinomaKaren MacDonald, Marc Pondel, Ivo AbrahamJournal of Medical Economics|March 16, 2024
Quantifying preferences for urea cycle disorder treatments using a discrete choice experimentJosiah Edelblut, Jeffrey R Skaar, John Hilton, et al.Journal of Medical Economics|March 12, 2024
Microsimulation model of the cost-effectiveness of anifrolumab compared to belimumab in the United Arab EmiratesGihan Hamdy Elsisi, Ahmed Abogamal Waleed, Walid Al Shehhy, et al.Journal of Medical Economics|March 21, 2024
Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinibMasayuki Saruta, Isao Kawaguchi, Yuji Ogawa, et al.Journal of Medical Economics|March 11, 2024
The cost-effectiveness of zuranolone versus selective serotonin reuptake inhibitors for the treatment of postpartum depression in the United StatesLasair O'Callaghan, Elizabeth Chertavian, Scott J Johnson, et al.Journal of Medical Economics|September 13, 2024
Short- and long-term cost-effectiveness of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis in ChinaYin Shi, Yanwu Zhou, Shuishi Li, et al.Journal of Medical Economics|February 29, 2024
Post-approval indications and clinical trials for cardiovascular drugs: some implications of the US Inflation Reduction ActHenry Grabowski, Genia LongPageof 241